IMU Biosciences
Entity

  • IMU Biosciences

    Created in 2019
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    4,283

  • Activities

    healthtech biotech deeptech

  • Technologies

    A.I.

  • Entity types

    Startup

  • Location

    London, UK

    London

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 42

  • Engaged corporates

    4
    0 4

  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    Mapping the immune system across health and disease to power precision medicine

    Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.

    digital health, immunology, immune medicine, precision medicine, and AI/ML

  • IMU Biosciences | Powering Precision Medicine

    IMU is unlocking the potential of the immune system. Through innovative and comprehensive systems level immunophenotyping and advanced AI and ML analytics, IMU is generating, harmonising and translating vast system level immune data into actionable insights and tools to drive the development of precision medicine across a range of health conditions and treatment responses.

    • https://www.imubiosciences.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Dia & Co
Dia & Co
Semiconductors, Retail Apparel and Fashion
Dia & Co
Semiconductors, Retail Apparel and Fashion 		Other

7 Oct 2024


Virgin
Virgin
Media, Venture Capital and Private Equity Principals
Virgin
Media, Venture Capital and Private Equity Principals 		Other

23 Sep 2024


UCB
UCB
Pharmaceutical Manufacturing
UCB
Pharmaceutical Manufacturing 		Other

7 Jul 2024


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing 		Other

7 Jul 2024


Similar entities
Last news
Show all articles
Social network dynamics